Gene · 4522
Papers1,437
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,437
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial Metabolism in the Spotlight: Maintaining Balanced RNAP III Activity Ensures Cellular Homeostasis. | Int J Mol Sci | 2023 | 37834211 | PubTator, text mining | PubMed |
| Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer. | Acta Pharm Sin B | 2023 | 37799388 | PubTator, text mining | PubMed |
| Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals. | Cancers (Basel) | 2023 | 37760474 | PubTator, text mining | PubMed |
| Molecular Classifiers in Skin Cancers: Challenges and Promises. | Cancers (Basel) | 2023 | 37760432 | PubTator, text mining | PubMed |
| Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer's Disease. | Cells | 2023 | 37759500 | PubTator, text mining | PubMed |
| Retinopathy as an initial sign of hereditary immunological diseases: report of six families and challenges in eye clinic. | Front Immunol | 2023 | 37711606 | PubTator, text mining | PubMed |
| Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis. | Redox Biol | 2023 | 37703668 | PubTator, text mining | PubMed |
| Editorial: The intersection of gene regulation and metabolism in cardiovascular disease. | Front Genet | 2023 | 37701624 | PubTator, text mining | PubMed |
| Genome-wide identification of transcriptional enhancers during human placental development and association with function, differentiation, and disease†. | Biol Reprod | 2023 | 37694817 | PubTator, text mining | PubMed |
| Amlodipine downregulates gene expression that involved in the signaling pathways of coagulation process in COVID-19 patients: An observational clinical study. | J Adv Pharm Technol Res | 2023 | 37692005 | PubTator, text mining | PubMed |
| Biallelic MTHFD1 variants presenting as severe combined immunodeficiency. | Clin Immunol | 2023 | 37690615 | PubTator, text mining | PubMed |
| Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy. | Front Oncol | 2023 | 37664062 | PubTator, text mining | PubMed |
| Antiviral effects of interferon-stimulated genes in bats. | Front Cell Infect Microbiol | 2023 | 37661999 | PubTator, text mining | PubMed |
| A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. | Dis Model Mech | 2023 | 37661832 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease. | Nutrients | 2023 | 37630697 | PubTator, text mining | PubMed |
| Common Variants in One-Carbon Metabolism Genes (MTHFR, MTR, MTHFD1) and Depression in Gynecologic Cancers. | Int J Mol Sci | 2023 | 37628752 | PubTator, text mining | PubMed |
| Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment. | Antioxidants (Basel) | 2023 | 37627515 | PubTator, text mining | PubMed |
| Nuclear PTEN Regulates Thymidylate Biosynthesis in Human Prostate Cancer Cell Lines. | Metabolites | 2023 | 37623882 | PubTator, text mining | PubMed |
| Folate trapping is lethal to cancer cells. | Chem Biol Drug Des | 2023 | 37620162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4522/papers?page=6